Patients with type 2 diabetes who switched to tirzepatide rather than escalating their dulaglutide dosage had greater weight ...

Diabetes patients on dulaglutide (Trulicity) had better glycemic control and more weight loss if they switched to tirzepatide ...

Tirzapetide dose escalation schedules were slower in the real-world than clinical settings among individuals with obesity without T2D.

The study finds better A1c lowering and weight reduction, but an expert clinician says practical issues may pose barriers.

For patients with inadequately controlled T2D receiving dulaglutide, switching to tirzepatide is associated with additional HbA1c reduction and weight loss.

In the 731-patient SUMMIT study, participants were randomly assigned to either tirzepatide at a dose of between 2.5mg and 15mg per week or placebo, on top of their current heart failure treatment.

Semaglutide and tirzepatide were the least cost-effective ... “Alternative strategies, such as lower-dose maintenance programs after achieving maximum weight loss and integrating lifestyle ...

Eli Lilly has launched weight-loss drug Mounjaro in India, priced at Rs 3,500 per injection for a 2.5mg dose. Will high costs ...

2 Even with Eli Lilly’s recent self-pay alternative of a single-dose vial of tirzepatide at a 50% or greater discount, many Americans still cannot afford $5000 per year out-of-pocket.

Lexaria's oral capsules worthy of expanded investigation as a viable alternative to injected tirzepatide. KELOWNA, BC / ACCESS Newswire / March 18, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX ...

The researchers found that at week 40, the change from baseline in HbA1c was −1.44 and −0.67% with tirzepatide and dulaglutide escalation to 4.5mg or maximum tolerated dose, respectively.